Abbott Reports Fourth-Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Abbott Reports Fourth-Quarter 2015 Results
February 1, 2016 8:33 AM EST
UBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More
January 29, 2016 7:28 AM EST
William Blair downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $36.71 yesterday.
...
More
January 28, 2016 7:33 AM EST
Abbott (NYSE: ABT) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.27 billion.
GUIDANCE:
Abbott sees FY2016 EPS of $2.10-$2.20, versus the consensus of $2.26.
For earnings history and earnings-related data on Abbott (ABT) click here.
...
More
